| Kimberly Sokol, MD | |
|
101 The City Dr S, Orange, CA 92868-3201 | |
| (714) 456-7890 | |
| Not Available |
| Full Name | Kimberly Sokol |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 101 The City Dr S, Orange, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497160840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A135573 (California) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaweah Delta Medical Center | Visalia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
The stakes are high for the health law's future with the vote either sealing the measure's implementation or becoming its undoing. However, some of the changes it includes have already been internalized by the health care marketplace.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. (Beta cells are cells in the pancreas that produce insulin.) Three years of BYETTA therapy improved indices of beta-cell function assessed four weeks after discontinuing therapy. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) in Orlando, Fla.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
In an ongoing effort to combat the rise in wandering-related tragedies and deaths within the Autism Spectrum Disorder community, the National Autism Association announced today its launch of the "Big Red Safety Box Program" made possible by a generous grant from the American Legion Child Welfare Foundation.
Stereotaxis announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure.
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
The stakes are high for the health law's future with the vote either sealing the measure's implementation or becoming its undoing. However, some of the changes it includes have already been internalized by the health care marketplace.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. (Beta cells are cells in the pancreas that produce insulin.) Three years of BYETTA therapy improved indices of beta-cell function assessed four weeks after discontinuing therapy. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) in Orlando, Fla.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
In an ongoing effort to combat the rise in wandering-related tragedies and deaths within the Autism Spectrum Disorder community, the National Autism Association announced today its launch of the "Big Red Safety Box Program" made possible by a generous grant from the American Legion Child Welfare Foundation.
Stereotaxis announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure.
› Verified 2 days ago
| Entity Name | Regents Of The University Of |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154379394 PECOS PAC ID: 7517869605 Enrollment ID: O20040120001119 |
News Archive
The stakes are high for the health law's future with the vote either sealing the measure's implementation or becoming its undoing. However, some of the changes it includes have already been internalized by the health care marketplace.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. (Beta cells are cells in the pancreas that produce insulin.) Three years of BYETTA therapy improved indices of beta-cell function assessed four weeks after discontinuing therapy. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) in Orlando, Fla.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
In an ongoing effort to combat the rise in wandering-related tragedies and deaths within the Autism Spectrum Disorder community, the National Autism Association announced today its launch of the "Big Red Safety Box Program" made possible by a generous grant from the American Legion Child Welfare Foundation.
Stereotaxis announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Sokol, MD 111 Termino Ave, Unit B, Long Beach, CA 90803-6601 Ph: () - | Kimberly Sokol, MD 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-7890 |
News Archive
The stakes are high for the health law's future with the vote either sealing the measure's implementation or becoming its undoing. However, some of the changes it includes have already been internalized by the health care marketplace.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. (Beta cells are cells in the pancreas that produce insulin.) Three years of BYETTA therapy improved indices of beta-cell function assessed four weeks after discontinuing therapy. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) in Orlando, Fla.
Adocia announces positive results from a phase IIa clinical trial evaluating its innovative ultra-fast formulation of insulin Lispro in comparison to Eli Lilly's Humalog commercial insulin. Adocia's formulation incorporates proprietary BioChaperone technology which enables accelerated absorption of prandial insulins. Humalog, which is now off-patent, has annual sales of USD 2.6 billion.
In an ongoing effort to combat the rise in wandering-related tragedies and deaths within the Autism Spectrum Disorder community, the National Autism Association announced today its launch of the "Big Red Safety Box Program" made possible by a generous grant from the American Legion Child Welfare Foundation.
Stereotaxis announced that the recent BBC documentary "From the Heart" included a cardiac ablation procedure performed with the Stereotaxis System by Dr. Muchtiar Khan of OLVG Hospital in Amsterdam. The program's second half, beginning at 10:30 of the 25-minute run time, features extensive scenes from the Stereotaxis procedure.
› Verified 2 days ago
Joseph Villarreal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Scott Rudkin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Joelle Reynard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Dr. Inna Shniter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8113 | |
John C Fox, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Miss Shannon Louise Toohey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Drive South, Bldg 200 , Suite 710, Rt 128-01, Orange, CA 92868 Phone: 715-456-5239 | |
Wirachin Hoonpongsimanont, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5705 |